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Abstract
Background: Considering the increasing trend of obesity reported in current data, this study was
conducted to examine trends of obesity and abdominal obesity among Tehranian adults during a
median follow-up of 6.6 years.
Methods: Height and weight of 4402 adults, aged 20 years and over, participants of the Tehran
Lipid and Glucose Study (TLGS), were measured in 1999-2001(phase I) and again in 2002-
2005(phase II) and 2006-2008 (phase III). Criteria used for obesity and abdominal obesity defined
body mass index (BMI) ≥ 30 and waist circumference ≥ 94/80 cm for men/women respectively.
Subjects were divided into10-year groups and the prevalence of obesity was compared across sex
and age groups.
Results: The prevalence of obesity was 15.8, 18.6 and 21% in men and 31.5, 37.7 and 38.6% in
women in phases I, II and III respectively (p < 0.001). The prevalence of abdominal obesity in men
was 36.5, 57.2 and 63.3% and in women was 76.7, 83.8 and 83.6% in the three periods mentioned
(p < 0.001). Men aged between 20-29 years had highest increase rates of obesity and abdominal
obesity in phase III in comparison with phase I (with a respective rates of 2.2- and 3.3-fold). In both
sexes, an increased trend was observed between phases I and II, whereas between phases II and III,
this trend was observed in men, but not in women.
Conclusion: This study demonstrates alarming rises in the prevalences of both obesity and
abdominal obesity in both sexes especially in young men, calling for urgent action to educate people
in lifestyle modifications.
Background
Obesity, general and abdominal, poses one of the greatest
public health challenges for the 21st century with particu-
larly alarming trends in several parts of the world [1].
Unhealthy diets and physical inactivity are the main con-
tributors to overweight and obesity, which are among the
leading risk factors for the major non-communicable dis-
eases. The most significant consequences for health of
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overweight and obesity include hypertension and hyperl-
ipidaemia, coronary heart diseases, ischemic stroke, type
2 diabetes, certain kinds of cancer [2]. In 2005, the esti-
mated total numbers of overweight and obese adults
worldwide, were 937 million and 396 million respectively
[1], numbers that have doubled in comparison to 20 years
ago [3]; by 2030, these figures are projected to be 1.3 bil-
lion and 573 million for overweight and obese adults
respectively [1]. Recently there is a greater emphasis on
abdominal obesity, as compared with general obesity, in
relation to the risk of incidence of non-communicable
weigh-related diseases [4]. Studies show the prevalence of
abdominal obesity to be increasing along with general
obesity [5]; for instance, in NHANES, during 10 years
(from 1994 to 2004), an increase of 10% was observed in
the prevalence of abdominal obesity among American
adults [6].
In Iran, the prevalence of overweight and obesity in 2005
was reported to be 42.8% in men and 57% in women [7];
for 2015, the figures are predicted to be 54 and 74%
respectively [8]. Studies have shown that the prevalence of
abdominal obesity to range between 9.7 - 12.9% and 54.5
- 63.7% in Iranian men and women respectively [7,9].
There is however limited data available on this trend from
Iran.
The Tehran Lipid and Glucose Study (TLGS) with median
follow-up of 3.6 years [10] reported an increasing trend
for prevalence of obesity and abdominal obesity in both
sexes. We conducted this survey with the objective of
determining this trend in Tehranian adults between the
years 1999 and 2008 (with median follow-up of 6.6
years).
Methods
General information
The Tehran Lipid and Glucose Study was conducted to
determine the risk factors of atherosclerosis among
Tehran's urban population and to develop population-
based measures to prevent the rising trend of diabetes
mellitus and dyslipidemia. The design of this study
encompasses three major components; phase I, a cross-
sectional prevalence study of cardiovascular disease and
associated risk factors and phases II and III, prospective
follow-ups study for 20 years [11]. A multistage stratified
cluster random sampling technique was used to select
15,005 people, aged 3 years or older, from district 13 of
Tehran, the capital of the Iran; the district is located in the
center of Tehran and the age distribution of its population
is representative of the overall population of Tehran.
From this population, only individuals above 20 years
old, who participated in phase I in 1999-2001, phase II in
2002-2005 and phase III in 2006-2008 were chose. The
interval between two assessments was at approximately
3.6-year intervals in this survey. The details of this study
have been published elsewhere [12].
Data collection
After excluding subjects aged < 20 years (n = 4637), those
with missed values of weight, height, or other variables (n
= 485), or lost to follow-up (n = 5481), data of 4402 sub-
jects including 41.6% men (1835 persons) with a com-
plete 6.6-year follow-up was used in this cohort study.
There were 708 subjects in the 20-29 years age group,
1088 aged 30-39 years, 983 aged 40-49 years, 828 aged
50-59 years, 655 between 60 and 69 years, and 140 aged
70 years and over. In comparison to those who completed
the follow-up, individuals lost to follow-up had lower
value of systolic blood pressure (119 vs. 117 mmHg), fast-
ing plasma glucose (4.99 vs. 4.94 mmol/L), age (44.5 vs.
41.5 years), BMI (27.1 vs. 26.5 Kg/m2) and waist circum-
ference (89.1 vs. 87.2 cm) (p < 0.001).
This study was approved by the Research Ethics Commit-
tee of the Research Institute for Endocrine Sciences, Sha-
hid Beheshti University of Medical Sciences, and
informed written consent was obtained from all subjects
and was conducted in accordance with the principles of
the Declaration of Helsinki.
Anthropometric measures
Weight and height were determined using a digital elec-
tronic weighing scale (Seca 707; range 0.1-150 kg, Hano-
ver, MD) with an accuracy of up to 100 gr (the machine
was regularly checked for precision after every 10 meas-
urements) and tape meter stadiometer respectively. Waist
and hip circumferences were measured using standard
protocols by a trained individual. Waist circumference
was measured at the level of the umbilicus and hip cir-
cumference was measured over light clothing at the widest
girth of the hip. Body mass index [BMI = weight (kg)/
height2 (m2)] and waist-to-hip ratio [WHR = waist cir-
cumference (cm)/hip circumference (cm)] were calcu-
lated; according to the International Obesity Task Force
(IOTF) guidelines, overweight was determined as BMI >
25 and < 30, obesity was defined as BMI ≥ 30 [13], WC ≥
94 cm in men and ≥ 80 cm in women was considered as
the cut-offs for determining abdominal obesity [14].
Statistical analysis
All variables are expressed as mean (SE) or percent. The
means between 3 phases were compared using the
repeated measurement test and comparison of over-
weight, obesity and abdominal obesity percentage
between 3 phases was done using the Cochran test. Bon-
ferroni correction was used for multiply comparison
between these phases. In each phase, logistic models were
developed to evaluate the role of sex in prediction of over-
weight, obesity and abdominal obesity separately. AgeBMC Public Health 2009, 9:426 http://www.biomedcentral.com/1471-2458/9/426
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adjusted prevalence was estimated with the reference pop-
ulation group of Tehran according to the data from the
2006 census. All analyses were stratified by sex. All tests
for statistical significance were two-tailed and performed
assuming a type I error probability of < 0.05. All data were
analyzed by the SPSS soft ware package (SPSS for Win-
dows; SPSS Inc., Chicago, IL, USA; Version 16.00).
Results
The mean ages of subjects in the 3 phases were 44.5, 48
and 50.9 years respectively. Of 4402 study participants, of
58.4% (n = 2567) were women. Mean Body Mass Index
(BMI) was 27.1, 27.9 and 28.2 Kg/m2 in phase I, II and III,
respectively; and mean WC was 89.1, 93.3 and 93.9 cm,
respectively.
Mean (SE) for BMI, WC and WHR increased significantly
in all age groups, in both sexes, between phase I and III.
Whereas in men, WC increased in all age groups between
the mentioned phases, increases for women were
observed only between phases I and II (Table 1).
Sex-specific prevalences of overweight, obesity and 
abdominal obesity
Overall prevalence of overweight, obesity and abdominal
obesity in both sexes are showed in Table 2; while age
adjusted prevalence of overweight, obesity and abdomi-
nal obesity in baseline were 55.4, 14.4 and 303% in men
and 64.5, 22.9 and 68% in women, respectively. Percent-
ages of overweight, obesity and abdominal obesity have
risen significantly in both sexes through three phases
mentioned, (p < 0.001) (Table 2). In phase III, The high-
Table 1: Mean (SE) of BMI, WC and WHR in three phases of TLGS.
Age group
(years)
Number BMI(kg/m2)W C  ( c m ) W H R
Phase I Phase II Phase III Phase I Phase II Phase III Phase I Phase II Phase III
Men
20-29 266 24.6 (0.3) 26.0 (0.3) 27.1 (0.3)* 83.0 (0.8) 91.0 (0.8) 95.0 (0.7)* 0.86 (0.00) 0.91 (0.00) 0.94 (0.00)*
30-39 459 26.2 (0.2) 27.0 (0.2) 27.6 (0.2)* 88.3 (0.5) 94.4 (0.5) 96.2 (0.5)* 0.90 (0.00) 0.93 (0.00) 0.96 (0.00)*
40-49 369 26.6 (0.2) 27.2 (0.2) 27.4 (0.2)* 90.8 (0.5) 95.7 (0.5) 97.0 (0.5)* 0.93 (0.00) 0.95 (0.00) 0.97 (0.00)*
50-59 319 26.5 (0.2) 26.8 (0.2) 26.4 (0.2)* 92.1 (0.6) 96.2 (0.6) 97.4 (0.5)* 0.95 (0.00) 0.97 (0.00) 0.99 (0.00)*
60-69 328 26.5 (0.2) 26.7 (0.2) 26.5 (0.2)† 93.0 (0.6) 97.1 (0.6) 97.7 (0.6)* 0.95 (0.00) 0.98 (0.00) 1.00 (0.00)*
≥ 70 94 25.4 (0.4) 25.7 (0.4) 25.5 (0.4) 90.7 (1.0) 94.9 (1.0) 95.7 (0.9)* 0.95 (0.00) 0.98 (0.00) 0.99 (0.00)*
Total 1835 26.1 (0.1) 26.7 (0.1) 27.1(0.1)* 89.6 (0.3) 95.0 (0.2) 96.6 (0.2)* 0.92 (0.00) 0.95 (0.00) 0.97 (0.00)*
Women
20-29 442 24.4 (0.2) 25.8 (0.2) 26.4 (0.2)* 78.0 (0.5) 81.5 (0.5) 81.4 (0.5)* 0.77 (0.00) 0.80 (0.00) 0.80 (0.00)*
30-39 629 27.2 (0.2) 28.5 (0.2) 28.7 (0.2)* 85.2 (0.4) 89.1 (0.4) 88.7 (0.5) * 0.81 (0.00) 0.84 (0.00) 0.84 (0.00)*
40-49 614 29.2 (0.2) 30.1 (0.2) 30.4 (0.2)* 91.5 (0.5) 95.0 (0.4) 95.0 (0.4)* 0.85 (0.00) 0.88 (0.00) 0.88 (0.00)*
50-59 509 29.6 (0.2) 30.2 (0.2) 30.5 (0.2)* 94.4 (0.5) 97.8 (0.5) 97.7 (0.5)* 0.88 (0.00) 0.91 (0.00) 0.91 (0.00)*
60-69 327 28.8 (0.2) 29.4 (0.2) 29.3 (0.2)* 95.0 (0.6) 98.0 (0.6) 97.2 (0.6)* 0.91 (0.00) 0.93 (0.00) 0.93 (0.00)*
≥ 70 46 27.0 (0.6) 27.4 (0.6) 27.4 (0.6)† 92.7 (1.7) 95.0 (1.6) 94.3 (1.8) 0.91 (0.01) 0.94 (0.01) 0.94 (0.01)*
Total 2567 27.9 (0.1) 28.9 (0.1) 29.1 (0.1)* 88.7 (0.2) 92.2 (0.2) 91.9 (0.3)* 0.84 (0.00) 0.87 (0.00) 0.87 (0.00)*
SE: Standard Error, BMI: Body Mass Index, WC: Waist Circumference, WHR: Waist to Hip Ratio, TLGS: Tehran Lipid and Glucose Study,
* p < 0.001; † p < 0.01 as compared to values in Phase I.BMC Public Health 2009, 9:426 http://www.biomedcentral.com/1471-2458/9/426
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est prevalence of overweight and abdominal obesity was
found in the 40-49 and 60-69 year-old groups of both
sexes, respectively. The maximum prevalence of obesity
was seen in 30-39-year-old men and 50-59-year old
women. Although a higher prevalence of abdominal obes-
ity was seen in women (p < 0.001), a slight decrease was
observed in phase III.
Changes in BMI, WC and WHR in both sexes
The trends of changes in BMI, WC and WHR from phase I
to II showed increases in both sexes, significantly more so
in women. Among men, this trend increased from phase
II to III, while in women it was relatively stable (Figure 1A,
B, C). Trends of overweight, obesity and abdominal obes-
ity in women increased from phases I to III, the rate
decreasing between phases II and III in women, but not so
in men (Figure 1D, E, F).
Figure 2 shows relative changes in BMI, WC, overweight,
obesity and abdominal obesity in the different age groups
of men and women. Among both sexes, the highest rise in
BMI was observed among 20-29 year-olds, with a smaller
peak being observed among 30-39-years-olds. In men,
changes in WC were substantially larger between phases I
and II than between II and III, a trend not observed in
women (Figure 2A, B). Men showed a greater change in
prevalence of overweight, obesity and abdominal obesity,
particularly in the youngest age group (20-29 years) (Fig-
ure 2C, D, E).
Table 2: The prevalences of Overweight, Obesity and Abdominal obesity in three phases of TLGS.
Age group (years) Number Overweight, % Obesity, % Abdominal obesity, %
Phase I Phase II Phase III Phase I Phase II Phase III Phase I Phase II Phase III
Men
20-29 266 40.6 55.3 67.3* 10.5 17.6 22.9* 16.1 38.7 53.7*
30-39 459 59.9 69.0 74.3* 15.9 30.7 24.6* 32.6 54.6 61.4*
40-49 369 67.5 74.6 75.1* 15.2 50.3 22.77* 37.6 61.5 65.0*
50-59 319 66.8 69.0 70.8 20.7 47.9 19.7 45.7 62.3 67. 7*
60-69 328 66.8 66.5 66.5 16.8 41.8 16.5 48.4 66.4 69.2*
≥ 70 94 52.1 54.2 48.9 13.8 19.6 12.8 35.1 55.3 57.4*
Total 1835 60.6 66.9 70.1 15.8 37.8 21.1* 36.5 57.2 63.3*
Women
20-29 442 41.8 55.7 59.0* 11.8 17.6 18.1* 43.8 54.9 55.2*
30-39 629 69.3 78.3 80.9* 23.2 30.7 33.7* 68.9 80.2 79.8*
40-49 614 82.7 88.3 89.6* 40.4 50.3 49.0* 86.3 92.1 92.5*
50-59 509 84.3 88.2 88.6* 44.4 47.9 52.0* 91.9 94.6 93.9†
60-69 327 81.6 83.1 82.9 38.2 41.8 40.9 92.3 95.7 95.4†
≥ 70 46 73.9 78.3 73.9 17.4 19.6 26.7 89.1 93.4 89.1
Total 2567 72.4 79.4 80.9* 31.3 37.8 38.6* 76.7 83.8 83.6*
TLGS: Tehran Lipid and Glucose Study, Overweight: BMI = 24.9-29.9, Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women 
respectively, * p < 0.001, † p < 0.01 as compared to values in Phase IBMC Public Health 2009, 9:426 http://www.biomedcentral.com/1471-2458/9/426
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Median 6.6-years changes in BMI(A), WC(B), WHR(C), and prevalences of overweight(D), obesity(E) and abdominal obesity(F) Figure 1
Median 6.6-years changes in BMI(A), WC(B), WHR(C), and prevalences of overweight(D), obesity(E) and 
abdominal obesity(F). BMI: Body Mass Index, WC: Waist circumference, WHR: Waist to Hip Ratio, Overweight: BMI = 
24.9-29.9, Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women respectively * p < 0.001 as compared to val-
ues in Phase I.
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Median 6.6-years, age-group specific changes in BMI(A), WC(B) and the prevalences of overweight(C), obesity(D) and abdomi- nal obesity(E) Figure 2
Median 6.6-years, age-group specific changes in BMI(A), WC(B) and the prevalences of overweight(C), obes-
ity(D) and abdominal obesity(E). BMI: Body Mass Index, WC: Waist circumference, Overweight: BMI = 24.9-29.9, Obes-
ity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women respectively.
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An association was observed between female gender and
overweight, obesity and abdominal obesity in all 3
phases, but the strength of this association decreased
between phase II and III (p < 0.001) (Table 3).
Discussion
The results of this study show an increasing trend of obes-
ity and abdominal obesity in the urban adult Tehranian
population over 6.6 years. The prevalence of obesity
increased 33 and 23% in men and women respectively;
abdominal obesity during this period, showed increase of
71% in men and 9% in women. Thus, the increasing trend
of abdominal obesity was dramatically higher in men
than in women; also at the end of follow up the preva-
lences of abdominal obesity in men and women were 63
and 84%, respectively.
This high increase in the prevalence of obesity and
abdominal obesity may be due to changes in lifestyle and
shifts in nutritional patterns in Iran, [15] attributable to
industrialization and substitution of high-fat, refined car-
bohydrate, and low-fiber diets [16]. The shift in the frame-
works of occupations, transportation systems and the
nature of activities related to occupations and leisure both
in Iran [17] and worldwide, [18] has led to lower levels of
physical activity, a main contributor to the increasing
trend in obesity and abdominal obesity. In addition, we
found that the distribution of prevalence of obesity did
not change much, and a remarkable shift towards higher
prevalence of abdominal obesity was observed. These
findings are in agreement with literature available from
USA [6] and Finland [19]. Explanations for the upward
trend in abdominal obesity in comparison with fewer
changes in obesity may be related to the changes in health
behaviour over time. Several studies have shown lifestyle
factors to be associated with body fat distribution [19], for
example a decrease in physical activity level, increased
smokers and changes in trans fat and fiber consumption
[20].
Recent studies show the trend of obesity and abdominal
obesity to be increasing, in both developed and develop-
ing countries [18,19,21]. This trend rose from 12 to 23%
in USA over 15 years [22] and from 43 to 52% in Jordan
over 10 years [23], as a developing country. Our findings
indicate that the prevalence of Tehranian obese adults is
increased from 25 to 31% during 6.6 years; the difference
may be due to varying cultures of societies, the socio-eco-
nomic status of populations and design and sample size
of studies. Although the trend of abdominal obesity is
seen to be increasing in all studies, describing and com-
paring the prevalence of abdominal obesity in different
populations is somewhat problematic because different
cut points have been use in different studies.
In agreement with other studies worldwide[1,24] and in
Iran [7,9,25], our findings show that the prevalences of
obesity and abdominal obesity in women are higher than
men; gender differences in food intake, physical activity
level and psycho-socio-economic status may be responsi-
ble for this difference. For example, results of a survey
showed that Tehranian women consume more sweets and
simple sugars [26]. In addition, lower physical activity lev-
els among women, several pregnancies, lower socio-eco-
nomic status, unemployment in many Tehranian women,
a higher ratio of depression, and lower education level
may be some of the reasons for the susceptibility of
women to obesity as compared to men [17]. In contrast of
our results, the prevalence of obesity in Kuwait [27] and
abdominal obesity in Palestin among women was lower
than men [28]; which can be due to differences in cultures
of the Arab and Iranian populations.
In this study, we provide evidence that the trends of obes-
ity and abdominal obesity are more alarming in men than
in women, which can be due to the importance given by
women to their health, because of their increasing educa-
tional levels and more income in recent years. It can also
be a result of public educational programs being focused
more on women as the target group because of their
higher obesity levels compared to men. Moreover ignor-
ing men in implemented public educational programs,
Table 3: The OR(95% CI) of overweight, obesity and abdominal 
obesity in women(n = 2567) compared to men(n = 1835) in three 
phases.
Odds ratio (95% CI)
Phase I Phase II Phase III
Overweight:
Men 1.0 1.0 1.0
Women 1.7 (1.5-1.9) 1.9 (1.7-2.2) 1.8 (1.6-2.0)
Obesity:
Men 1.0 1.0 1.0
Women 2.4 (2.0-2.8) 2.6 (2.3-3.0) 2.3 (2-2.6)
Abdominal Obesity:
Men 1.0 1.0 1.0
Women 5.7(5.0-6.5) 3.9(3.4-4.4) 2.9(2.5-3.4)
OR: odds ratio, CI: confidence interval, Overweight: BMI = 24.9-29.9, 
Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/
women respectively.BMC Public Health 2009, 9:426 http://www.biomedcentral.com/1471-2458/9/426
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causes the trend of obesity got worse among them com-
pared to women during recent years. Our findings are con-
sistent with recently published studies from Sweden
[29,30], England [31] and Greece [32], showing the
upward trends both in general and abdominal obesity
among men (especially in the youngest group), compared
to these levels remaining stable among women during
recent years.
Regarding both the strengths and limitations of our study,
the main strength of our study is first large population-
based study with 6.6 years follow up of a same population
in Iran, and the Middle East Region. The main limitation
of our analyses, a considerable fraction of subjects (about
fifty percent) was lost during the follow-up period due to
immigration. Considering that those who lost to follow
up had lower BMI and WC compared to those who com-
pleted study, we may have overestimated the reported
trend in overweight, obesity and abdominal obesity in
this population.
Conclusion
In conclusion, an alarming increase was shown in the
prevalences of overweight, obesity and abdominal obesity
among in both sexes of Tehranian adults, the highest
trend being observed in the 20-29 year age groups, espe-
cially in men. There is the urgent need to target younger
ages for prevention and implementation of public educa-
tional programs to curtail this rising trend in obesity and
abdominal obesity especially in young men.
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